Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have a medical diagnosis of epilepsy and have had at least one seizure in the past 6 months (confirmed through medical records via a signed medical release form)
- People who are willing to keep their current medication the same or reduce it, based on their prescribing doctor's advice
- People who are available to attend an intake session, a baseline assessment, a post-treatment assessment, a 6-month follow-up, and 45 treatment sessions
- People who are willing to wear an Oura ring at all times (except when charging it) for the whole duration of the study
Who may not be able to join:
- People who are under 17 years of age
- People with current substance use
- People with a personality disorder diagnosis
- People with heavy metal toxicity
- People with mold toxicity
- People whose metabolic test results fall outside certain thresholds (confirm with trial site for details)
- People whose current medication has been increased in dose or type
- People who have been prescribed any new medications (reductions as directed by a prescribing doctor are acceptable)
- People who currently have a brain bleed
- People who have had an acute traumatic brain injury within the last 12 months
- People with a history of brain stimulation treatments, including electroconvulsive therapy (ECT)
- People who have brain implants, pumps, or shunts
- People with a history of brain surgery
- People currently on hormone replacement therapy for menopause or gender transition
- People with untreated sleep disorders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cynthia Kerson, PhD, Saybrook University
Phone: 415-515-3243
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Subjective level of stress
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.